Cathie Wood's ARK ETFs have disclosed their daily ... Additionally, ARK bought 78,752 shares of 10X Genomics Inc (NASDAQ:TXG) for a total of $1,122,216, reinforcing the fund's focus on life ...

Cathie Wood’s ARK ETFs have disclosed their daily trades for ... Additionally, ARK bought 78,752 shares of 10X Genomics Inc (NASDAQ:TXG) for a total of $1,122,216, reinforcing the fund’s focus on life ...

Barclays lowered the firm’s price target on 10x Genomics to $18 from $19 and keeps an Overweight rating on the shares. The firm expects the life science tools and diagnostics group to be down ...

10x Genomics (NASDAQ:TXG – Get Free Report)‘s stock had its “sell (e+)” rating restated by equities researchers at Weiss Ratings in a note issued to investors on Friday,Weiss Ratings reports.

Whitaker, Chief Legal Officer of 10x Genomics. "We are pleased with this resolution on ATAC as we continue to defend the asserted Brenner patents on appeal." The company's litigation against Parse ...

Biotech company 10x Genomics (NASDAQ:TXG) will be reporting earnings tomorrow after market hours. Here’s what to look for. 10x Genomics missed analysts’ revenue expectations by 5% last quarter ...

Try Now>> See the top stocks recommended by analysts >> Read More on TXG: 10x Genomics NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

Bird, Ali vs. Frazier, Yankees vs. Red Sox. In the financial world, CNBC’s Jim Cramer and ARK Invest’s Cathie Wood stand as modern adversaries, their clashing investment styles drawing ...

10x Genomics Price Performance Shares of TXG opened at $12.31 on Tuesday. The firm has a market cap of $1.49 billion, a PE ratio of -8.05 and a beta of 1.85. The stock’s fifty day moving average ...